Cytek Biosciences, Inc.

Cytek develops and sells cell analysis instruments, reagents, software, and services for biomedical research and clinical diagnostics. Its core products include full spectrum flow cytometers and cell sorters under the Aurora and Northern Lights brands, as well as conventional and imaging systems under the Amnis and Guava lines. The company also provides automated sample loaders, antibody cocktail preparation systems, reagent kits, and analysis software such as SpectroFlo and Cytek Cloud. Customers include pharmaceutical and biotechnology companies, contract research organizations, academic and governmental research institutions, and clinical laboratories.

Headquartered in Fremont, California, the company maintains manufacturing operations there as well as in San Diego, Seattle, Wuxi, and Singapore. Cytek employs more than 700 people, including over 270 commercial staff and more than 150 research and development personnel. It sells products globally through direct sales forces in North America, Europe, and Asia-Pacific, alongside distributor networks serving Latin America and the Middle East.

Summary of the business section of Cytek Biosciences's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of December 31, 2025, we had 702 full-time employees.”